Other efforts have purified T cell receptor (TCR) genes from both CD4+ (DR4) and CD8+ (A2) T cells specific to CLDN6 that were obtained from a patient with ovarian cancer. This evidence concerns the gene CLDN6 and ovarian carcinoma.